Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Hepatitis

Free Subscription 06.10.2025 1 AIDS 1 Am J Gastroenterol 1 Arch Virol 1 BMC Cancer 2 BMC Gastroenterol 1 Dig Dis Sci 2 Gut 2 Hepatology 1 J Med Virol 4 J Viral Hepat 1 PLoS One 1 PLoS Pathog 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. MARTIN-CARMONA J, Corona-Mata D, Tellez F, Navarrete Lorite MN, et al
   Long-term liver stiffness dynamics after sustained virological response in patients with HIV/HCV co-infection and advanced fibrosis.
   AIDS. 2025 Sep 24. doi: 10.1097/QAD.0000000000004357.
   PubMed         Abstract available
   
   

   
   Am J Gastroenterol

2. SINGH V, Sharma AK, Narasimhan LR, Bhalla A, et al
   Correction to: Granulocyte Colony-Stimulating Factor in Severe Alcoholic Hepatitis: A Randomized Pilot Study.
   Am J Gastroenterol. 2025 Sep 25. doi: 10.14309/ajg.0000000000003739.
   PubMed        
   
   

   
   Arch Virol

3. ERDIN M, Altan E, Suomalainen N, Alburkat H, et al
   Genetic characterization of rat hepatitis E virus (Rocahepevirus ratti) in urban brown rats (Rattus norvegicus) in Helsinki, Finland.
   Arch Virol. 2025;170:215.
   PubMed         Abstract available
   
   

   
   BMC Cancer

4. LIU SY, Zhu L, Lu WF, Xie GL, et al
   Preoperative HBsAg seroclearance affects long-term outcomes for hepatitis B virus-related hepatocellular carcinoma after liver resection: a multicenter analysis.
   BMC Cancer. 2025;25:1467.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

5. KUCUK I, Salmanoglu M, Bas S
   Resolvin D1 values in patients with alcohol-associated liver disease.
   BMC Gastroenterol. 2025;25:661.
   PubMed         Abstract available
   
   
6. DOU Y, Zhang L, Wang H
   Differences and clinical significance of liver - kidney function parameters, inflammatory markers and peripheral blood T lymphocyte subsets in patients with HBV - related acute - on - chronic liver failure.
   BMC Gastroenterol. 2025;25:663.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

7. CHEN Y, Feng H, Bao Y, Yan M, et al
   Cost-Effectiveness of Risk-Score-Based Surveillance Strategies for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B.
   Dig Dis Sci. 2025 Sep 27. doi: 10.1007/s10620-025-09419.
   PubMed         Abstract available
   
   

   
   Gut

8. TSENG TC, Yang HI, Kao JH
   Reply: Prevalence of serum HBsAg <100 IU/mL in inactive chronic hepatitis B.
   Gut. 2025 Sep 27:gutjnl-2025-336947. doi: 10.1136/gutjnl-2025-336947.
   PubMed        
   
   
9. TSENG TC, Yang HI, Kao JH
   Reply to: 'Rethinking "inactive chronic hepatitis B": should we treat patients with high HBsAg levels?'.
   Gut. 2025 Sep 27:gutjnl-2025-336618. doi: 10.1136/gutjnl-2025-336618.
   PubMed        
   
   

   
   Hepatology

10. SANDULESCU O, Dudman SG, Gmizic I, Garcia F, et al
    Global Hepatitis C elimination: Updates, challenges, and opportunities from real-world experiences in Europe and North America.
    Hepatology. 2025 Sep 26. doi: 10.1097/HEP.0000000000001548.
    PubMed        
    
    
11. SUN Y, Chen S, Zhao X, You H, et al
    Reply: Clarifying LSM cutoff validation, statistical power, and subgroup applicability in predicting liver- related events in chronic hepatitis B.
    Hepatology. 2025 Oct 2. doi: 10.1097/HEP.0000000000001559.
    PubMed        
    
    

    
    J Med Virol

12. STENBACK JB, Schmidt D, Noborg U, Gustafsson J, et al
    Accurate and Cost-Efficient Whole Genome Sequencing of Hepatitis B Virus Using Nanopore.
    J Med Virol. 2025;97:e70630.
    PubMed         Abstract available
    
    

    
    J Viral Hepat

13. GONZALEZ CJ, Perez-Mejia CN, Hernandez N, Kapadia SN, et al
    Identifying Varying Influences on Eliminating Hepatitis C Across Medical Specialties.
    J Viral Hepat. 2025;32:e70093.
    PubMed         Abstract available
    
    
14. LAUREILLARD D, Binh NT, Vinh VH, Hong TT, et al
    High Efficiency and Safety of Hepatitis C Treatment Among People Who Inject Drugs in Vietnam.
    J Viral Hepat. 2025;32:e70090.
    PubMed         Abstract available
    
    
15. GHANY MG, Ward JW, Baldwin Z, Jiao S, et al
    HCV Testing and Treatment of Adults in the United States: 2014 Through 2021-Data From Two National Commercial Testing Laboratories.
    J Viral Hepat. 2025;32:e70087.
    PubMed         Abstract available
    
    
16. QURESHI H, Canchola JA, Hai G, Latif AQ, et al
    Evaluation of Blood Droplet Volumes on the Cobas Plasma Separation Card for HCV RNA Testing in Resource-Limited Settings.
    J Viral Hepat. 2025;32:e70091.
    PubMed         Abstract available
    
    

    
    PLoS One

17. DOMINGUEZ A, Torner N, Soldevila N, Varela C, et al
    Hepatitis A in Spain: Evolution of hospitalization in the period 2000-2021.
    PLoS One. 2025;20:e0332317.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

18. THORSELIUS CE, Kok A, Fahnoe U, Wolfisberg R, et al
    In vivo and in vitro recombinant systems of a novel variant demonstrate cross-reactive neutralization for the HCV model virus, Norway rat hepacivirus.
    PLoS Pathog. 2025;21:e1013127.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

19. TANAKA T, Akaike Y, Kasai H, Yamashita A, et al
    Identification of claudin-3 as an entry factor for rat hepacivirus.
    Proc Natl Acad Sci U S A. 2025;122:e2508736122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.